🇺🇸 FDA
Patent

US 6132980

Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes

expired A61KA61K2039/51A61K2239/31

Quick answer

US patent 6132980 (Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/51, A61K2239/31, A61K2239/38, A61K2239/57